Explore 3 Stock Ideas & Industry Insights Download Free Report

Ardent Health Partners, Inc.

Healthcare US ARDT

7.83USD
-1.44(15.53%)

Last update at 2026-06-03T20:03:00Z

Day Range

7.718.48
LowHigh

52 Week Range

8.0715.48
LowHigh

Fundamentals

  • Previous Close 9.27
  • Market Cap1453.85M
  • Volume1914106
  • P/E Ratio10.58
  • Dividend Yield-%
  • EBITDA481.29M
  • Revenue TTM6324.34M
  • Revenue Per Share TTM44.93
  • Gross Profit TTM 3666.64M
  • Diluted EPS TTM0.96

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 286.36M 363.06M 151.61M 311.48M 295.89M
Minority interest -94.32400M -89.36500M -72.65300M -76.46200M -90.31800M
Net income 135.81M 210.34M 50.29M 188.91M 154.26M
Selling general administrative 1192.64M 1097.12M 3607.66M 3371.68M 3132.33M
Selling and marketing expenses - - 14.87M 956.26M 906.98M
Gross profit 6168.64M 3431.32M 4416.08M 4174.52M 3943.07M
Reconciled depreciation 155.70M 146.29M 140.84M 138.17M 137.20M
Ebit 325.58M 409.63M 209.15M 393.53M 389.72M
Ebitda 481.29M 555.92M 350.00M 531.70M 526.92M
Depreciation and amortization 155.70M 146.29M 140.84M 138.17M 137.20M
Non operating income net other - - - - -
Operating income 325.58M 405.76M 229.50M 802.84M 322.72M
Other operating expenses 5998.76M 5603.01M 5179.98M 5867.83M 5361.16M
Interest expense 55.20M 65.58M 65.42M 82.05M 93.83M
Tax provision 56.22M 63.35M 20.78M 46.11M 51.31M
Interest income - - - - -
Net interest income -55.20200M -65.57800M -65.42500M -82.05200M -93.83400M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 56.22M 63.35M 22.64M 46.11M 51.31M
Total revenue 6324.34M 5966.07M 5409.48M 5129.69M 4870.40M
Total operating expenses 5843.05M 3068.26M 5200.04M 4912.66M 4410.47M
Cost of revenue 155.70M 2534.76M 993.40M 955.17M 927.33M
Total other income expense net -39.22600M -42.70200M -77.89000M -491.36100M -26.83400M
Discontinued operations - - - - -
Net income from continuing ops 230.13M 299.71M 122.94M 265.37M 244.58M
Net income applicable to common shares - - - - -
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 5290.21M 4956.10M 4731.56M 4859.88M -
Intangible assets 89.33M 76.93M 76.93M 76.93M -
Earning assets - - - - -
Other current assets 544.53M 417.84M 299.57M 234.01M -
Total liab 3605.24M 3433.74M 3649.24M 3809.57M -
Total stockholder equity 1686.21M 1521.20M 670.90M 639.05M -
Deferred long term liab - - - - -
Other current liab 565.16M 519.74M 422.49M 387.48M -
Common stock 1.43M 1.43M 496.88M 510.97M -
Capital stock - - - - -
Retained earnings 501.61M 365.80M 155.45M 101.55M -
Other liab - - - - -
Good will 879.45M 852.08M 844.70M 844.70M -
Other assets - - -371.20900M - -
Cash 709.60M 556.78M 437.58M 456.12M -
Cash and equivalents - - - - -
Total current liabilities 1046.54M 945.42M 994.10M 808.60M -
Current deferred revenue - - 18.02M 17.35M -
Net debt 1554.86M 1725.40M 1959.04M 1932.23M -
Short term debt 23.44M 55.62M 61.03M 65.63M -
Short long term debt 23.44M 9.23M 18.61M 16.09M -
Short long term debt total 2264.46M 2282.19M 2396.62M 2388.35M -
Other stockholder equity 1186.79M 1144.24M -174.01400M - -
Property plant equipment - - - - -
Total current assets 2058.82M 1832.75M 1618.09M 1409.25M -
Long term investments - - - - -
Net tangible assets - - - - -
Short term investments - - 8.70M 21.40M -
Net receivables 686.10M 743.03M 775.45M 611.96M -
Long term debt 1075.78M 1085.82M 1168.25M 1161.90M -
Inventory 118.59M 115.09M 105.48M 107.15M -
Accounts payable 457.94M 401.25M 474.54M 320.80M -
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -3.61000M 9.74M 18.56M 26.53M -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 111.69M 142.97M 138.01M 93.98M -
Deferred long term asset charges - - - - -
Non current assets total 3231.38M 3123.35M 3113.47M 3450.62M -
Capital lease obligations 1218.73M 1187.14M 1209.76M 1210.37M -
Long term debt total - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -220.46000M -137.98300M 46.58M -136.25900M
Change to liabilities - - - - -
Total cashflows from investing activities -214.22900M - - - -
Net borrowings -7.98800M - - - -
Total cash from financing activities -103.46500M 24.64M -102.26200M -270.33100M -283.90700M
Change to operating activities - - - - -
Net income 230.13M 299.71M 53.90M 188.91M 154.26M
Change in cash 152.82M 119.21M -18.54700M -262.11200M 658.57M
Begin period cash flow 556.78M 437.58M 456.12M 718.24M 59.66M
End period cash flow 709.60M 556.78M 437.58M 456.12M 718.24M
Total cash from operating activities 470.51M 315.03M 221.70M -38.35900M 146.91M
Issuance of capital stock 0.00000M 208.66M 0.00000M 0.00000M -
Depreciation 155.70M 146.29M 140.84M 138.17M 137.20M
Other cashflows from investing activities 0.18M -1.70700M -0.57500M -8.68600M 1.47M
Dividends paid - 0.00000M 0.00000M 174.81M 62.13M
Change to inventory -3.14800M -9.40700M 1.67M 4.67M -5.73100M
Change to account receivables 59.16M 40.00M -181.09900M -17.18400M -96.46500M
Sale purchase of stock - - - - -
Other cashflows from financing activities -95.47700M -67.25900M -95.23600M -79.11100M -137.33200M
Change to netincome - - - - -
Capital expenditures 211.90M 187.51M 137.41M 151.11M 139.00M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -3.34100M -181.75100M -56.31100M -325.65400M -261.12500M
Stock based compensation 39.29M 17.98M 0.90M 0.61M 0.55M
Other non cash items 5.13M 8.76M 78.36M -86.51300M 146.67M
Free cash flow 258.61M 127.52M 84.29M -189.46600M 7.91M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ARDT
Ardent Health Partners, Inc.
-1.44 15.53% 7.83 10.58 9.09 0.23 1.10 0.48 6.09
HCA
HCA Healthcare, Inc.
-4.12 1.12% 363.23 13.19 13.66 1.13 293.44 1.77 8.22
FSNUY
Fresenius SE & Co KGaA ADR
-0.18 1.69% 10.50 16.87 9.44 0.42 0.78 0.79 5.37
JDHIY
JD Health International Inc
0.08 1.48% 5.33 62.50 35.97 0.30 2.32 0.16 3.90
JDHIF
JD Health International Inc
- -% 5.85 57.75 32.68 0.29 2.11 0.16 3.90

Reports Covered

Stock Research & News

Profile

Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers, urgent care centers, free-standing emergency departments, and diagnostic imaging centers. The company operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. Ardent Health, Inc. was formerly known as Ardent Health Partners, Inc. and changed its name to Ardent Health, Inc. in June 2025. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health, Inc. is a subsidiary of EGI-AM Investments, L.L.C.

Ardent Health Partners, Inc.

340 Seven Springs Way, Brentwood, TN, United States, 37027

Key Executives

Name Title Year Born
Mr. Martin J. Bonick FACHE, M.H.A. President, CEO & Director 1973
Mr. Alfred Lumsdaine CPA Chief Financial Officer 1965
Mr. Stephen Christopher Petrovich Executive VP, General Counsel, Chief Legal Officer & Secretary 1967
Mr. David W. Schultz President of Hospital Operations 1971
Jess Botros Vice President of IT Strategy & Operations NA
Mr. David Byers CPA Senior VP & Chief Accounting Officer 1981
Mr. Lonnie Garrison PMP Chief Technology Officer NA
Ms. Anika Gardenhire B.S.N., R.N. Chief Digital & Information Officer 1983
Mr. David Anthony Styblo C.F.A. Senior Vice President of Investor Relations NA
Mr. Jason Ehrlinspiel Chief Compliance Officer 1970

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.